Gufic BioScience

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE742B01025
  • NSEID: GUFICBIO
  • BSEID: 509079
INR
355.40
-2.75 (-0.77%)
BSENSE

Dec 05

BSE+NSE Vol: 34.09 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Net Sales
819.81
806.67
Other Operating Income
0.00
0.00
Total Operating income
819.81
806.67
Raw Material Cost
344.20
331.26
Purchase of Finished goods
55.41
58.06
(Increase) / Decrease In Stocks
-24.91
0.57
Employee Cost
127.05
109.63
Power Cost
0.00
0.00
Manufacturing Expenses
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
Other Expenses
183.37
161.26
Total Expenditure (Excl Depreciation)
685.12
660.79
Operating Profit (PBDIT) excl Other Income
134.69
145.88
Other Income
3.63
2.18
Operating Profit (PBDIT)
138.32
148.06
Interest
23.11
15.36
Exceptional Items
0.00
0.00
Gross Profit (PBDT)
115.21
132.70
Depreciation
21.06
17.02
Profit Before Tax
94.14
115.67
Tax
24.49
29.54
Provisions and contingencies
0.00
0.00
Profit After Tax
69.65
86.14
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
69.65
86.14
Share in Profit of Associates
0.00
0.00
Minority Interest
0.00
0.00
Other related items
0.00
0.00
Consolidated Net Profit
69.65
86.14
Equity Capital
10.03
10.03
Face Value
1.0
1.0
Reserves
591.05
522.53
Earnings per share (EPS)
6.94
8.59
Diluted Earnings per share
6.95
8.74
Operating Profit Margin (Excl OI)
16.43%
18.08%
Gross Profit Margin
14.05%
16.45%
PAT Margin
8.5%
10.68%
Public Share Holdings (%)
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 1.63% vs 16.80% in Mar 2024

stock-summary

Standalone Net Profit

YoY Growth in year ended Mar 2025 is -18.82% vs 8.08% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -7.47% vs 8.34% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 50.46% vs 86.86% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has fallen from Mar 2024

Compare Annual Results Of Gufic BioScience With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
819.81
398.25
421.56
105.85%
Other Operating Income
0.00
0.00
0.00
Total Operating income
819.81
398.25
421.56
105.85%
Raw Material Cost
344.20
91.64
252.56
275.60%
Purchase of Finished goods
55.41
89.83
-34.42
-38.32%
(Increase) / Decrease In Stocks
-24.91
-0.76
-24.15
-3,177.63%
Employee Cost
127.05
60.37
66.68
110.45%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
183.37
67.47
115.90
171.78%
Total Expenditure (Excl Depreciation)
685.12
308.55
376.57
122.05%
Operating Profit (PBDIT) excl Other Income
134.69
89.70
44.99
50.16%
Other Income
3.63
19.26
-15.63
-81.15%
Operating Profit (PBDIT)
138.32
108.96
29.36
26.95%
Interest
23.11
21.55
1.56
7.24%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
115.21
87.41
27.80
31.80%
Depreciation
21.06
16.84
4.22
25.06%
Profit Before Tax
94.14
70.57
23.57
33.40%
Tax
24.49
12.23
12.26
100.25%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
69.65
58.34
11.31
19.39%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
69.65
58.34
11.31
19.39%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.22
-0.22
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
69.65
58.56
11.09
18.94%
Equity Capital
10.03
46.05
-36.02
-78.22%
Face Value
1.00
10.00
0.00
Reserves
591.05
740.13
-149.08
-20.14%
Earnings per share (EPS)
6.94
12.72
-5.78
-45.44%
Diluted Earnings per share
6.95
16.12
-9.17
-56.89%
Operating Profit Margin (Excl OI)
16.43%
23.73%
0.00
-7.30%
Gross Profit Margin
14.05%
23.13%
0.00
-9.08%
PAT Margin
8.50%
15.43%
0.00
-6.93%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 819.81 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 1.63% vs 16.80% in Mar 2024

Annual - Standalone Net Profit
Standalone Net Profit 69.93 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -18.82% vs 8.08% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 134.99 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -7.47% vs 8.34% in Mar 2024

Annual - Interest
Interest 23.11 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 50.46% vs 86.86% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.47%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has fallen from Mar 2024